Characteristics of pain patients with opioid-use disorder

Psychosomatics

Volumn 51, Issue 3, 2010, Pages 257-266

  Haller, Deborah L ^a   Acosta, Michelle C ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CENTRAL STIMULANT AGENT; FENTANYL; GABAPENTIN; HYDROCODONE BITARTRATE PLUS PARACETAMOL; HYDROMORPHONE; LOCAL ANESTHETIC AGENT; METHADONE; MOOD STABILIZER; MORPHINE SULFATE; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PERCOCET; PETHIDINE; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; NARCOTIC ANALGESIC AGENT; STREET DRUG;

ADULT; ALCOHOLISM; ANALGESIC AGENT ABUSE; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MACHIAVELLIANISM; MALE; MENTAL DISEASE; OPIATE ADDICTION; PATIENT COMPLIANCE; PERSONALITY; PERSONALITY DISORDER; PRESCRIPTION; COMORBIDITY; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; HEALTH BEHAVIOR; MENTAL DISORDERS; MIDDLE AGED; OPIOID-RELATED DISORDERS; PAIN; PAIN CLINIC; PATIENT REFERRAL; PERSONALITY TEST; PSYCHOLOGY; PSYCHOMETRY; QUALITY OF LIFE; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS;

ACTIVITIES OF DAILY LIVING; ADULT; ALCOHOLISM; ANALGESICS, OPIOID; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH BEHAVIOR; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; OPIOID-RELATED DISORDERS; PAIN; PAIN CLINICS; PERSONALITY INVENTORY; PSYCHOMETRICS; QUALITY OF LIFE; REFERRAL AND CONSULTATION; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 77953065785     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.51.3.257     Document Type: Article

References (45)

1. Substance Abuse and Mental Health Services Administration: Results from the 2005. National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. SMA 06-4194, Rockville, MD, 2006
2. Fishbain DA, Rosomoff HL, Steele-Rosomoff D: Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain 1992; 8:77-85
3. Chabal C, Erjavec MK, Jacobson L, et al: Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin J Pain 1997; 13:150-155 (Pubitemid 27251109)
4. Hoffman NG, Olofsson O, Salen B, et al: Prevalence of abuse and dependency in chronic pain patients. Int J Addictions 1995; 30:919-927
5. Kouyanou K, Pither CE, Wessely S: Medication misuse, abuse, and dependence in chronic pain patients. J Psychosom Res 1997; 43:497-504 (Pubitemid 27487541)
6. Reid MC, Engles-Horton LL, Weber MB, et al: Use of opioid medications for chronic non-cancer pain syndromes in primary care. J Gen Intern Med 2002; 17:173-179 (Pubitemid 34603843)
7. Manchikanti L, Fellows B, Damron KS, et al: Prevalence of illicit drugs among individuals with chronic pain in the Commonwealth of Kentucky: an evaluation of patterns and trends. J Ky Med Assoc 2005; 103:55-62
8. Fleming MF, Balousek SL, Klessig CL, et al: Substance-use disorders in a primary-care sample receiving daily opioid therapy. Pain 2007; 8:573-582 (Pubitemid 46991033)
9. Adams LL, Gatchel RJ, Robinson RC, et al: Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage 2004; 27:440-459
10. Butler SF, Budman SH, Fernandez K, et al: Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004; 112(1-2):65-75 (Pubitemid 39371021)
11. Edlund MJ, Steffick D, Hudson T, et al: Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 2007; 129:355-362 (Pubitemid 46754578)
12. Ives TJ, Chelminski PR, Hammett-Stabler CA, et al: Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res 2006; 6:46
13. Sullivan MD, Edlund MJ, Steffick D, et al: Regular use of prescribed opioids: association with common psychiatric disorders. Pain 2005; 119(1-3):95-103 (Pubitemid 41752969)
14. Weaver M, Schnoll S: Abuse liability in opioid therapy for pain treatment in patients with an addiction history. Clin J Pain 2002; 18(suppl 4):S61-S69 (Pubitemid 34815395)
15. Wesson DR, Ling W, Smith DE: Prescription of opioids for treatment of pain in patients with addictive disease. J Pain Symptom Manage 1993; 8:289-296 (Pubitemid 23191392)
16. Knight K, Holcom M, Simpson DD: TCU Psychosocial Functioning and Motivation Scales: Manual on Psychometric Properties. Fort Worth, TX, Texas Christian University, Institute of Behavioral Research, 1994
17. Derogatis LR, Melisaratos N: The Brief Symptom Inventory: an introductory report. Psychol Med 1983; 13:595-605
18. Costa PT, McCrae RR: NEO-Five Factor Inventory (NEO-FFI). Available from Sigma Assessment Systems, 1992
19. Kerns RD, Turk DC, Rudy TE: The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985; 4:345-356
20. Millon T, Antoni M, Millon C, et al: Behavioral Medicine Diagnostic (MBMD). Available from Pearson Assessments, 2001
21. Haller DL, Olbrisch ME: Substance use and other behavioral health concerns in chronic pain patients: preliminary report on the Behavioral Health Inventory (BHI). Proceedings of the 61st Annual Scientific Meeting, College on Problems of Drug Dependence, 2000
22. Sherbourne CD, Stewart AL: The MOS Social Support Survey. Soc Sci Med 1991; 32:705-714
23. Cruciani RA, Sekine R, Homel P, et al: Measurement of QTc in patients receiving chronic methadone therapy. J Pain Symptom Manage 2005; 29:385-391 (Pubitemid 40602519)
24. Savage SR: Long-term opioid therapy: assessment of consequences and risks. J Pain Symptom Manage 1996; 11:274-286 (Pubitemid 26129963)
25. Heit HA: The truth about pain management: the difference between a pain patient and an addicted patient. Eur J Pain 2001; 5(suppl A):27-29 (Pubitemid 33713668)
26. Sees LL, Clark H: Opioid use in the treatment of chronic pain: assessment of addiction. J Pain Symptom Manage 1993; 8:257-264
27. Brooner RK, King VL, Kidorf M, et al: Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry 1997; 54:71-80 (Pubitemid 27044701)
28. Kidorf M, Disney ER, King VL, et al: Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe-exchange program. Drug Alcohol Depend 2004; 74:115-122 (Pubitemid 38501685)
29. Rosenblum A, Joseph H, Fong C, et al: Prevalence and characteristics of chronic pain among chemically-dependent patients in methadone maintenance and residential treatment facilities. JAMA 2003; 289:2370-2380 (Pubitemid 37430169)
30. Jamison RN, Kauffman J, Katz NP: (2000). Characteristics of methadone-maintenance patients with chronic pain. J Pain Symptom Manage 2000; 19:53-62 (Pubitemid 30067624)
31. Grachev ID, Fredickson BE, Apkarian AV: Dissociating anxiety from pain: mapping the neuronal marker N-acetyl aspartate to perception distinguishes closely interrelated characteristics of chronic pain. Mol Psychiatry 2001; 6:256-260
32. Melzack R: The Puzzle of Pain. New York, Basic Books, 1993
33. Al Absi M, Rokke PD: Can anxiety help us tolerate pain? Pain 1991; 46:43-51
34. Kain ZN, Sevarino F, Alexander GM, et al: Preoperative anxiety and postoperative pain in women undergoing hysterectomy: a repeated measures design. J Psychosom Res 2000; 49:417-422 (Pubitemid 32229224)
35. van den Hout JH, Vlaeyen JW, Houben RM, et al: The effects of failure feedback and pain-related fear on pain report, pain tolerance, and pain avoidance in chronic low back pain patients. Pain 2001; 92:247-257
36. Weisenberg M, Aviram O, Wolf Y, et al: Relevant and irrelevant anxiety in the reaction to pain. Pain 1984; 20:371-383 (Pubitemid 15176780)
37. Asghari A, Nicholas MK: Personality and pain-related beliefs/ coping strategies: a prospective study. Clin J Pain 2006; 22: 10-18 (Pubitemid 44378557)
38. Tanum L, Malt UF: Personality and physical symptoms in nonpsychiatric patients with functional gastrointestinal disorder. J Psychosom Res 2001; 50:139-146 (Pubitemid 32377372)
39. Bottlender M, Soyka M: Impact of different personality dimensions (NEO Five-Factor Inventory) on the outcome of alcoholdependent patients 6 and 12 months after treatment. Psychiatry Res 2005; 136:61-67 (Pubitemid 41032974)
40. Fisher LA, Elias JW, Ritz K: Predicting relapse to substance use as a function of personality dimensions. Alcohol Clin Exp Res 1998; 22:1041-1107
41. McCormick RA, Dowd ER, Quirk S, et al: The relationship of NEO-PI performance to coping styles, patterns of use, and triggers for use among substance abusers. Addict Behav 1998; 23: 497-507 (Pubitemid 28311337)
42. Quirk SW, McCormick RA: Personality subtypes, coping styles, symptom correlates, and substance of choice among a cohort of substance abusers. Assess 1998; 5:157-169
43. Zilberman ML, Tavares H, el-Guebaly N: Relationship between craving and personality in treatment-seeking women with substance-related disorders. BMC Psychiatry 2003; 3:1 (Pubitemid 38729333)
44. Ramírez-Maestre C, Martínez AEL, Zarazaga RE: Personality characteristics as differential variables of the pain experience. J Behav Med 2004; 27:147-165
45. Roome P, Humphrey M: Personality factors in analgesic usage. Stress Med 1992; 8:237-240